ORCID "Gonullu, Emel/0000-0002-6990-4206" Fakülteler için listeleme
-
BIOLOGIC DRUG PREFERENCES OF TURKISH RHEUMATOLOGISTS IN SPONDILOARTROPATHY PATIENTS WITH ADVANCED CHRONIC RENAL DISEASE
Mercan, Rıdvan; Tezcan, M. E.; Yağız, B.; Ateş, A.; Küçükşahin, O.; Bilge, N. S. Yaşar; Kanitez, N. A. (Bmj Publishing Group, 2022)[Abstract Not Available] -
THE DIFFERENCES BETWEEN THE FIRST PREFERRED BIOLOGICAL DMARD AND THE DRUG SURVIVAL IN GERIATRIC AND YOUNGER ADULT POPULATION WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS: TREASURE REAL-LIFE DATA
Gönüllü, E.; Kalyoncu, U.; Yağız, B.; Ateş, A.; Küçükşahin, O.; Bilge, N. S. Yaşar; Kanitez, N. A.; Mercan, Rıdvan (Bmj Publishing Group, 2022)[Abstract Not Available] -
PARADOXICAL REACTIONS, ESPECIALLY PSORIASIS IN RHEUMATOLOGY PATIENTS RECEIVING BIOLOGIC THERAPY FROM THE TREASURE DATABASE: A 5-YEAR FOLLOW-UP STUDY
Yağız, B.; Lermi, N.; Coşkun, B. N.; Dalkılıç, E.; Kiraz, S.; Ertenli, A. I.; Bilgin, E.; Mercan, Rıdvan (Bmj Publishing Group, 2022)[Abstract Not Available] -
Tuberculin skin test before biologic and targeted therapies: does the same rule apply for all?
İlgen, Ufuk; Karadağ, Ömer; Emmungil, Hakan; Küçükşahin, Orhan; Koca, Süleyman Serdar; Erden, Abdulsamet; Kalyoncu, Umut; Mercan, Rıdvan (Springer Heidelberg, 2022)This study aimed to compare Tuberculin Skin Test (TST) and QuantiFERON (R)-TB Gold In-Tube (QFT-GIT) test in rheumatoid arthritis (RA) and spondyloarthritis (SpA) patients scheduled for biological and targeted synthetic ...